Evidence map›Paper›PMID 31035975›Full record

ArticleBMC complementary and alternative medicine2019

Effect of Celastrus orbiculatus in inhibiting Helicobacter pylori induced inflammatory response by regulating epithelial mesenchymal transition and targeting miR-21/PDCD4 signaling pathway in gastric epithelial cells.

Yaodong Zhu, Lei Liu, Lei Hu, Wenqing Dong, Mei Zhang, Yanqing Liu, Ping Li

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review of Phytochemical Potency as a Natural Anti-Molecules (Basel, Switzerland) · 2023
    Review
  3. Article
  4. Review
  5. Article
  6. Function of Non-coding RNA inFrontiers in molecular biosciences · 2021
    Review
  7. PDCD4-mediated downregulation ofCentral-European journal of immunology · 2021
    Article
  8. Article
  9. Integrative cancer therapies
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yaodong ZhuChinese Integrative Medicine Oncology Department, First Affiliated Hospital of Medical University of Anhui, Hefei, 230000, Anhui, China. zhuyaodong2013@163.com.ORCID http://orcid.org/0000-0003-4874-1054
Lei LiuGeneral Surgery Department, First Affiliated Hospital of Medical University of Anhui, Hefei, 230000, Anhui, China.
Lei HuEmergency Department, First Affiliated Hospital of Medical University of Anhui, Hefei, 230000, Anhui, China.
Wenqing DongChinese Integrative Medicine Oncology Department, First Affiliated Hospital of Medical University of Anhui, Hefei, 230000, Anhui, China.
Mei ZhangChinese Integrative Medicine Oncology Department, First Affiliated Hospital of Medical University of Anhui, Hefei, 230000, Anhui, China.
Yanqing LiuInstitute of Combining Chinese Traditional and Western Medicine, Medical College, Yangzhou University, Yangzhou, 225009, Jiangsu, China.
Ping LiChinese Integrative Medicine Oncology Department, First Affiliated Hospital of Medical University of Anhui, Hefei, 230000, Anhui, China.
Anhui Medical University · CNYangzhou University · CN

Funding

Natural Science Foundation of Anhui Province 1708085QH189Young Scientists Fund 81603439
6 · The paper itself

Abstract

backgroundThe extract of Celastrus orbiculatus (COE) have been studied for anti-Helicobacter pylori (H. pylori) activity and anti-cancer effects in vitro and in vivo. However, the molecular mechanism by which COE inhibits H. pylori-induced inflammatory response has not been fully elucidated so far.

methodsThe effects of COE on viability, morphological changes, inflammatory cytokine secretion, protein and mRNA expression were analyzed by MTT assay, enzyme-linked immunosorbent assay (ELISA), immunofluorescence, western blot and real-time PCR (RT-PCR), respectively. The methylation level of programmed cell death 4 (PDCD4) promoter was investigated by methylation-specific PCR. (MSP) .

resultsCOE effectively inhibited the H.pylori-induced inflammatory response by regulating epithelial-mesenchymal transition (EMT). The methylation level of PDCD4 promoter was suppressed by COE, which increased the expression ofPDCD4. Moreover, COE could inhibit microRNA-21 (miR-21) expression, as shown by an enhancement of its target gene PDCD4. Furthermore, both miR-21 over-expression and PDCD4 silencing attenuated the anti-inflammatory effect. of COE.

conclusionsCOE inhibits H. pylori induced inflammatory response through regulating EMT, correlating with inhibition of miR-21/PDCD4 signal pathways in gastric epithelial cells.

Indexed as

Helicobacter pyloriAnti-Inflammatory AgentsApoptosis Regulatory ProteinsCelastrusCell LineCytokinesEpithelial CellsEpithelial-Mesenchymal TransitionGastric MucosaHelicobacter InfectionsHumansMicroRNAsPlant ExtractsRNA-Binding ProteinsSignal TransductionAnti-Inflammatory AgentsApoptosis Regulatory ProteinsCytokinesMicroRNAsMIRN21 microRNA, humanPDCD4 protein, humanPlant ExtractsRNA-Binding ProteinsCelastrus orbiculatusEpithelial mesenchymal transitionInflammatory responsemiR-21PDCD4

Identifiers

PMID31035975
PMCPMC6489279
OpenAlexW2947939172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.